Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 2401 | 2187 | 40.5 | 87% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1432 | 7402 | THROMBOPOIETIN//ONCOSTATIN M//LEUKEMIA INHIBITORY FACTOR |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | IL 6 RECEPTOR | Author keyword | 32 | 48% | 2% | 49 |
| 2 | INTERLEUKIN 6 RECEPTOR | Author keyword | 31 | 42% | 3% | 57 |
| 3 | GP130 | Author keyword | 24 | 23% | 4% | 92 |
| 4 | SOLUBLE INTERLEUKIN 6 RECEPTOR | Author keyword | 22 | 45% | 2% | 37 |
| 5 | SOLUBLE IL 6 RECEPTOR | Author keyword | 15 | 49% | 1% | 23 |
| 6 | HUMAN INTERLEUKIN 6 RECEPTOR | Author keyword | 12 | 86% | 0% | 6 |
| 7 | TRANS SIGNALLING | Author keyword | 12 | 86% | 0% | 6 |
| 8 | SGP130FC | Author keyword | 11 | 78% | 0% | 7 |
| 9 | IL 6R | Author keyword | 10 | 40% | 1% | 20 |
| 10 | TRANS SIGNALING | Author keyword | 7 | 57% | 0% | 8 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | IL 6 RECEPTOR | 32 | 48% | 2% | 49 | Search IL+6+RECEPTOR | Search IL+6+RECEPTOR |
| 2 | INTERLEUKIN 6 RECEPTOR | 31 | 42% | 3% | 57 | Search INTERLEUKIN+6+RECEPTOR | Search INTERLEUKIN+6+RECEPTOR |
| 3 | GP130 | 24 | 23% | 4% | 92 | Search GP130 | Search GP130 |
| 4 | SOLUBLE INTERLEUKIN 6 RECEPTOR | 22 | 45% | 2% | 37 | Search SOLUBLE+INTERLEUKIN+6+RECEPTOR | Search SOLUBLE+INTERLEUKIN+6+RECEPTOR |
| 5 | SOLUBLE IL 6 RECEPTOR | 15 | 49% | 1% | 23 | Search SOLUBLE+IL+6+RECEPTOR | Search SOLUBLE+IL+6+RECEPTOR |
| 6 | HUMAN INTERLEUKIN 6 RECEPTOR | 12 | 86% | 0% | 6 | Search HUMAN+INTERLEUKIN+6+RECEPTOR | Search HUMAN+INTERLEUKIN+6+RECEPTOR |
| 7 | TRANS SIGNALLING | 12 | 86% | 0% | 6 | Search TRANS+SIGNALLING | Search TRANS+SIGNALLING |
| 8 | SGP130FC | 11 | 78% | 0% | 7 | Search SGP130FC | Search SGP130FC |
| 9 | IL 6R | 10 | 40% | 1% | 20 | Search IL+6R | Search IL+6R |
| 10 | TRANS SIGNALING | 7 | 57% | 0% | 8 | Search TRANS+SIGNALING | Search TRANS+SIGNALING |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | STIMULATORY FACTOR II | 101 | 47% | 7% | 162 |
| 2 | IL 6 RECEPTOR | 75 | 40% | 7% | 148 |
| 3 | GP130 | 56 | 26% | 9% | 189 |
| 4 | HUMAN IL 6 | 48 | 65% | 2% | 45 |
| 5 | INTERLEUKIN 6 RECEPTOR | 37 | 32% | 4% | 98 |
| 6 | HUMAN INTERLEUKIN 6 RECEPTOR | 34 | 65% | 1% | 32 |
| 7 | HUMAN IL 6 RECEPTOR | 31 | 71% | 1% | 25 |
| 8 | BSF 2 IL 6 | 24 | 55% | 1% | 30 |
| 9 | HEPATOCYTE STIMULATING FACTOR | 18 | 28% | 3% | 55 |
| 10 | SOLUBLE INTERLEUKIN 6 RECEPTOR | 18 | 28% | 2% | 53 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| The pro- and anti-inflammatory properties of the cytokine interleukin-6 | 2011 | 268 | 134 | 51% |
| The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition | 2015 | 4 | 57 | 56% |
| Directing transition from innate to acquired immunity defining a role for IL-6 | 2005 | 344 | 62 | 52% |
| INTERLEUKIN-6 FAMILY OF CYTOKINES AND GP130 | 1995 | 869 | 110 | 34% |
| IL-6: from its discovery to clinical applications | 2010 | 172 | 43 | 42% |
| IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6 | 2012 | 75 | 100 | 67% |
| Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer | 2006 | 254 | 113 | 58% |
| THE BIOLOGY OF INTERLEUKIN-6 | 1989 | 1701 | 64 | 69% |
| INTERLEUKIN-6 AND THE ACUTE PHASE RESPONSE | 1990 | 1747 | 191 | 62% |
| INTERLEUKIN-6 IN BIOLOGY AND MEDICINE | 1993 | 933 | 381 | 44% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SECT PATHOPHYSIOL | 5 | 24% | 0.8% | 18 |
| 2 | CLIN PLICAT BIOL | 5 | 50% | 0.3% | 7 |
| 3 | MED SCI 1 | 3 | 27% | 0.5% | 11 |
| 4 | JOINT PROT STRUCT | 2 | 18% | 0.5% | 10 |
| 5 | MOL PL BIOL SCI | 1 | 100% | 0.1% | 2 |
| 6 | EQUIPE CYTOKINE CANC | 1 | 40% | 0.1% | 2 |
| 7 | OPHTHALMOLITABASHI KU | 1 | 40% | 0.1% | 2 |
| 8 | ROSWELL PK MEM MOLEC CELLULAR BIOL | 1 | 40% | 0.1% | 2 |
| 9 | COLON MOL CELL BIOL | 1 | 19% | 0.2% | 4 |
| 10 | IMMUNE CELL SIGNAL TRANSDUCT UNIT | 1 | 33% | 0.1% | 2 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000164387 | UNIT IMMUNOMICROBIO ENVIRONM CARCINOGENESIS//ANTI INTERLEUKIN 6 ANTIBODY//AUTOCRINE AND PARACRINE LOOPS |
| 2 | 0.0000141471 | ONCOSTATIN M//LEUKEMIA INHIBITORY FACTOR//LEUKAEMIA INHIBITORY FACTOR |
| 3 | 0.0000140208 | HYPOTHALAMIC FACTORS//IL 6 MESSENGER RNA//INTRAUTERINE SURVIVAL |
| 4 | 0.0000133061 | INTERLEUKIN 11//INTERLEUKIN 11 RECEPTOR//IL 11 |
| 5 | 0.0000126250 | INTERDISCIPLINARY GERIATR ASSOC//INTERLEUKIN 6 POLYMORPHISM//UNIT BIOL GENET CANC HAEMATOL AUTOIMMUNE |
| 6 | 0.0000097220 | LONGEV SCI//HOSP GERIATR MED//TORAT MED |
| 7 | 0.0000095232 | MYELOMA BONE DISEASE//CAM DR//HEIM |
| 8 | 0.0000065959 | ERRMECEEA 1391//GENET MED OBSTET GYNECOL//SCIRRHOUS GASTRIC CARCINOMA |
| 9 | 0.0000065434 | CARDIOTROPHIN 1//CARDIOTROPHIN//ERK 1 AND 2 |
| 10 | 0.0000056612 | CILIARY NEUROTROPHIC FACTOR//CNTF//CNTFR ALPHA |